As a member-focused Association, our members are at the heart of everything we do at the PRI.
In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.
Find out more about the different ways you and your organization can get involved with the PRI’s activities.
- Microbiome Regulatory Science Support Work
- Pre-competitive Task Groups
- Year-round networking and project-related communication support
More than 100 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.
Select Microbiome Activity Segment
- All segments
- Microbiome Product Developer
- Microbiome Analysis Expertise (service provider)
- Microbiome Pre-Clinical Research (CRO)
- Microbiome Clinical Research (CRO)
- Microbiome Contract Manufacturing Organization (CMO)
- Microbiome Contract Development & Manufacturing Organization (CDMO)
- Other Expertise | Quality, Legal, IP, Regulatory Affairs, Management
- Microbiome Research & Technology (public)
- Investment | Incubator | Accelerator | Tech Transfer
- Pharma (Human)
- Pharma (Veterinary)
- Consumer Goods
- News & Events
- PRI Publications
Marketing Event Manager
Boston Analytical specializes in providing high-quality analytical testing services for the CMC (Chemistry, Manufacturing and Controls) parameters involved in drug development and release testing. Our cGMP, FDA registered analytical testing laboratory is equipped to conduct all relevant testing and related services, including analytical development, storage and stability testing and microbiology testing.
Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and other unmet medical needs. The company has built a strong patented-protected proprietary position for the treatment of Diabetes Mellitus Type 1 and Type 2, cancer cachexia and auto-immune diseases.
Chr. Hansen A/S
Director, Business Development
CosmosID® is a global leader in supporting the pharmaceutical sector with CLIA-certified, ICH-GCP compliant microbiome and microbial isolate solutions for applications such as pre-clinical, clinical, CMC and regulatory support. In addition to Next Generation Sequencing workflows, CosmosID also offers validated, industry-leading bioinformatics, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision.
CPS Research is an independent clinical research site located in Glasgow, Scotland. Established in 1988, we conduct clinical trials in Phases II to IV in Pharmaceuticals, Food Supplements, Medical Devices and Over the Counter (OTC) therapies. We offer a personalised service to a worldwide client base of both large and small pharmaceutical, biotech and food organisations. Our single tier management structure allows an easy flow of communication with our clients.